Daniel Nikic’s Post

A lot of news for UnitedHealth Group on the M&A front over the last 24 hours as the Steward Health Care deal is no longer and the Amedisys is close to being through regulatory. 👉🏻Steward Health Acquisition Steward Health Care, a for-profit that runs 31 hospitals in several states, is currently working through bankruptcy and State/Federal regulators were not keen on UNH/Optum acquiring. 💡 Optum already employs or is affiliated with over 90,000 physicians—more than 10% of the country’s total—and there were concerns of higher prices and reduced quality. 👉🏻Amedisys Acquisition Almost a year ago to the day (6/26/23) that this deal was announced for 3.6 billion for this home health and hospice provider. There was concern from day 1 as they had just acquired LHC home health for 5.4 billion months earlier. 💡Allowing UNH/Optum to acquire both assets would give them 10% of the home health and a smaller portion of the hospice space so the DOJ was working with both companies to accommodate the sale. Interested to get more details on both deals in the coming days but UNH is certainly looking to deploy capital in the M&A space. At the end of Q1, UNH reported having more than 28 billion in cash😳. They have authority to buyback 9 million shares this years (4-5 billion dollars) so this is a different avenue beyond that for returns. 🙌 Spend money in assets you own and turn expenses into businesses…. Sign of the times #healthcare #marketaccess

DarioHealth reports decreased revenue following Twill acquisition - MobiHealthNews #DarioHealth Revenue Decrease Post Twill Acquisition #Financial Performance: DarioHealth reports a decrease in revenue following the acquisition of Twill. The company's financial performance has been impacted by this acquisition. #Revenue Decline Analysis: The revenue decline is analyzed in detail, highlighting the factors contributing to this decrease in revenue post the Twill acquisition. #Impact of Acquisition: The blog post discusses the impact of the Twill acquisition on DarioHealth's overall financial performance and revenue generation. #Future Strategies: DarioHealth outlines its future strategies to address the revenue decline and improve its financial performance after the Twill acquisition. #Healthcare IT Implications: The implications of the revenue decrease following the Twill acquisition on the healthcare IT sector ai.mediformatica.com #revenue #acquisition #dariohealth #digital #strategic #management #newyork #platform #york #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3xeE4dL)

Risant Health investing $1B+ into Cone Health after acquiring it is pretty dang cool. Kudos to Kaiser Permanente's leadership. This is how M&A in healthcare should be done. #healthcare #hospitals #clinics #healthsystems #mergers #acquisitions #privateequity #leadership #strategy https://lnkd.in/gJtjtXpZ.

NEW: More public healthcare players are getting bought out. Revenue cycle management company R1 RCM recently announced it's going private via a buyout by two private equity firms — for a whopping $8.9 billion. It's the third public healthcare company to get bought out this summer. Experts think R1 RCM's megamerger is a sign of big deals to come for healthcare as PE firms finally break out their wallets again. Read about why PE is returning to the healthcare scene now, and what big buyers are betting on, in Business Insider: https://lnkd.in/ecmjy_Sg

An important market trend to watch! #SPACs might never fully go away if the ambitions of three new healthcare-focused shops have any sway. As initial public offerings are far and few between, and even reverse mergers have fallen by the wayside, blank-check companies might fill a gap in the public markets, or so their sponsors are betting. Voyager Acquisition filed for a $261 million IPO on Tuesday, Sim Acquisition’s $200 million plans appeared on Monday and Launch One Acquisition’s paperwork for a $200 million debuted last week. All three wrote in their S-1 documents that they hope to carry a company in the healthcare industry onto the public markets. Launch One wrote that it’s particularly interested in “life sciences, globally.” #IPO #capitalmarket #publicmarket #healthcare #lifescience #lifesciences #celltherapy #genetherapy #cellandgenetherapy #advancedtherapies #publicofferings #VoyagerAcquisition #SimAcquisition #LaunchOne #biotech #biotechnology #biotechnews

The next big wave of mergers and acquisitions in the #digital #health industry can’t come at a better time. The market conditions are certainly ripe for it. #Enventure #Healthcare #PrivateEquity #VentureCapital

Digital MSK is starting to fulfil its potential in 2024, IPO's likely in 2025 https://lnkd.in/eMiMZui5 The digital MSK (musculoskeletal) market is on the rise in 2024. MSK digital health solutions have raised $223M so far this year, already nearly double that of 2023’s $125M. Since 2010, more than $38 Billion has been invested in companies offering MSK solutions, including mergers and acquisitions. An example of a successful digital MSK IPO is Physitrack, which went public in 2021. It's likely that other companies will follow suit in the coming years. Overall, digital MSK is a promising area in healthcare technology, and 2025 could be a big year for IPOs in this space. So who could go public in the next 18 months? Hinge Health: Hinge Health is a digital health company that provides virtual physical therapy and pain management services. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. Sword Health: Sword Health is a digital health company that provides patients with access to physical therapy, pain management, and other services through a mobile app. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk  https://lnkd.in/eMiMZui5 #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy

PACS Group Inc. Successfully Completes $450 Million IPO - PACS Group Inc., a leading operator of post-acute care facilities, has successfully raised $450 million through its initial public offering, setting the stage for its next phase of growth. The Farmington, Utah-based company sold 21.4 million shares at $21 each, pricing them at the mid-point of its anticipated range and marking a robust investor interest by increasing the number of shares offered from the initially planned 19.05 million. - This pricing values PACS Group at a market capitalization of approximately $3.1 billion, based on the number of outstanding shares listed in its SEC filings. The company's robust growth trajectory and its expansive operation across nine states with over 200 facilities underscore its significant presence in the healthcare sector. Originally founded in 2013 with just two skilled nursing facilities in San Diego, PACS Group has expanded rapidly, highlighting its operational success and market demand for post-acute care services. - Financially, PACS Group has demonstrated strong performance with net income of $112.9 million on revenue of $3.1 billion in 2023, although this reflects a decrease in net income from $150.5 million the previous year, despite the increase in revenue from $2.4 billion. This growth in revenue alongside a decrease in net profit could indicate major reinvestments or increased operational costs which are important factors for potential investors to consider. - The IPO also significantly shifts the ownership structure of the company. Co-founders Jason Murray and Mark Hancock, who previously owned the company outright, sold a substantial portion of their holdings but will retain a combined ownership of 87.2% if the over-allotment option is not exercised. This still represents a considerable controlling stake, ensuring that the founders maintain a major influence over the company’s strategic direction. - The offering, managed by leading financial institutions including Citi, JPMorgan Chase & Co., and Truist, underscores the confidence in PACS Group’s business model and future prospects. The company's shares are set to begin trading on the New York Stock Exchange under the symbol "PACS," providing public investors an opportunity to partake in PACS Group’s ongoing growth. #PACSGroup #IPO #healthcareinvestment #NYSE #publicoffering #healthcareIndustry

It has been a wild past few years across the health care industry, and the health care mergers and acquisitions market has been no exception. With a significant amount of deal volume and high valuations in 2021 and 2022, and a corresponding cool-off in 2023, the M&A market has certainly been a part of the roller-coaster ride the industry has been going through. As we move through 2024, we anticipate seeing continued investment in innovative health care segments as the economy and markets stabilize. In our latest industry trends article, CLA (CliftonLarsonAllen)'s Jed Cheney walks us through examining the data of deal-making and how that can help you make more informed decisions on potential transactions.

SPAC Feed: PepperLime Health Acquisition in a regulatory filing said it continues to explore options other than liquidation. One option is a… - https://lnkd.in/eJiKveXV #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic #finance #business